StockNews.AI
DNA
StockNews.AI
182 days

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

1. Ginkgo Bioworks to present Q4 and full-year results on February 25, 2025. 2. Webcast available; questions can be submitted via social media or email. 3. Ginkgo Bioworks focuses on cell programming across diverse markets. 4. Their biosecurity division is enhancing infrastructure for biological threat response. 5. Upcoming presentation could significantly inform investors on company performance.

4m saved
Insight
Article

FAQ

Why Bullish?

Scheduled presentations often lead to positive investor sentiment and potential price increases, as seen previously in tech earnings reports.

How important is it?

The announcement of the presentation gives investors key insights that could influence trading decisions ahead of the event.

Why Short Term?

The immediate effects will likely be felt around the presentation date; similar to other quarterly announcements.

Related Companies

DNAGinkgo Bioworks
Presentation and Q&A session scheduled for post-market on Tuesday, February 25, 2025 , /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the fourth quarter and full year ended December 31, 2024, on Tuesday, February 25, 2025, beginning at 5:30 p.m. ET. The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available. To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to [email protected]. About Ginkgo Bioworks Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn. Ginkgo Bioworks Contacts: INVESTOR CONTACT: [email protected]  MEDIA CONTACT: [email protected] SOURCE Ginkgo Bioworks WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News